Live
- DEO suspends teacher accused of sexual assault
- PM ‘cursing’ Congress out of despair: Maharashtra Cong Chief
- Applications are invited for Junior Colleges Scheme District Scheduled Castes Development Officer Ramlal
- A nomination was filed on the second day for the Nagar Kurnool parliamentary seat
- SP Gaikwad inspected the Telangana Amarnath Saleswaram Jatara yatra arrangements
- Rahul Gandhi's decision to contest from Wayanad shows 'lack of confidence': BJP President Nadda
- IPL 2024: Delhi bowlers will go after all of SRH’s top-order batters, says head coach Ricky Ponting
- At Amroha rally, PM Modi sends out ‘meaningful’ message for Muslims and Hindus
- Tripura records highest 79.83 pc voter turnout in Northeast
- The government has to clear the confusion
US Congressmen seek briefing on drugs from India
A bipartisan group of powerful US lawmakers on Wednesday sought a congressional briefing on contaminated drugs from India and China used in the treatment of high blood pressure
Washington:A bipartisan group of powerful US lawmakers on Wednesday sought a congressional briefing on contaminated drugs from India and China used in the treatment of high blood pressure.
Since July last year, at least 15 recalls have been issued for a class of drugs known as angiotensin II receptor blockers (ARB), which are generally used to treat high blood pressure.
The recalls appear to be connected to at least two foreign drug manufacturing facilities – Zhejiang Huahai Pharmaceutical in China and Hetero Labs in India.
Both facilities have a history of troubling FDA inspection reports prior to the detection of trace amounts of carcinogens, the bipartisan energy and commerce Congressmen said in a letter to the US' Food and Drug Administration (FDA) Commissioner Scott Gottlieb.
Expressing concern, the lawmakers requested a briefing on drugs manufactured overseas that may have been contaminated with trace amounts of known carcinogens.
